Vaccines Coming To HK Will Be Safe: Sophia Chan

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2020-12-12 HKT 10:02

Share this story

facebook

  • The health minister is seeking to reassure the public the vaccines on the way are safe. Photo: RTHK

    The health minister is seeking to reassure the public the vaccines on the way are safe. Photo: RTHK

The Health Secretary Sophia Chan on Saturday said the government and experts will ensure the Covid-19 vaccines that Hong Kong buys are safe and effective before purchasing and offering them to citizens.

A million doses of Covid jabs made by mainland company Sinovac could arrive in Hong Kong as soon as next month, followed by the vaccines developed by the German firm BioNTech which are manufactured and distributed by China's Fosun Pharma.

Those are just the first batch of millions of doses that the SAR government had pre-ordered from the pharmaceutical firms.

Speaking on an RTHK radio programme, the minister stressed that local authorities will look at the final clinical data provided by the firms before paying, to ensure their safety and quality.

When asked if there are plans to halt the inoculation programme if a number of people show serious side effects, Professor Chan said the Department of Health has an existing mechanism in place overseeing vaccines' performance like the flu jabs.

She said health authorities would investigate if many people are found to have suffered serious side effects.

She added that the government is still working on plans as to how it can coordinate the transport and delivery of the vaccines, as one of the vaccines types, the BioNTech one, needs to be stored at -70 degrees Celsius or under.

Meanwhile, Professor David Hui, an infectious diseases expert advising the SAR government on its pandemic response, has urged people not to worry about where the vaccines are produced.

His comments come after some expressed worries over the quality of the jabs made on the mainland.

But Professor Hui said that shouldn't be a concern because each and every vaccine has to pass through relevant procedures to prove its effectiveness as it gains the approval from authorities.

Last updated: 2020-12-12 HKT 12:55

RECENT NEWS

ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education

ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more

Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets

The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more

Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation

Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more

MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending

MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more

Why The $2 Trillion Stablecoin Prediction Is Too Low

McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more

RedotPay Eyes US IPO With Potential US$1 Billion Raise

RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more